Global Health Limited (NSE:MEDANTA)
India
· Delayed Price · Currency is INR 1,235.55
+29.15 (2.42%)
Feb 21, 2025, 3:30 PM IST
Global Health Revenue
Global Health had revenue of 9.43B INR in the quarter ending December 31, 2024, with 13.31% growth. This brings the company's revenue in the last twelve months to 35.70B, up 12.75% year-over-year. In the fiscal year ending March 31, 2024, Global Health had annual revenue of 32.75B with 20.86% growth.
Revenue (ttm)
35.70B
Revenue Growth
+12.75%
P/S Ratio
9.31
Revenue / Employee
3.94M
Employees
9,052
Market Cap
331.85B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 267.20B |
| Mankind Pharma | 116.41B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 222.47B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |
Global Health News
- 18 days ago - Global Health shares surge over 4% as EBITDA jumps 11% YoY in Q3 - Business Upturn
- 2 months ago - Jefferies maintains Hold call on Medanta, target of Rs 1,170 - Business Upturn
- 3 months ago - Global Health (Medanta) shares rise over 2% as Medanta announces new 750-bed hospital in New Delhi - Business Upturn
- 3 months ago - Medanta to operate 750-bed super speciality hospital in Delhi, commits ₹600 crore capex - Business Upturn
- 6 months ago - Global Health (Medanta) shares surge over 5% in morning trade - Business Upturn